High-level production of recombinant human parathyroid hormone 1-34

被引：0
|
作者：
机构：
来源：
Appl Environ Microbiol | / 2卷 / 526-529期
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Electronically facilitated transdermal delivery of human parathyroid hormone (1-34)
    Medi, BA
    Singh, J
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2003, 263 (1-2) : 25 - 33
  • [32] Addressing the tertiary structure of human parathyroid hormone-(1-34)
    Pellegrini, M
    Royo, M
    Rosenblatt, M
    Chorev, M
    Mierke, DF
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (17) : 10420 - 10427
  • [33] A new method for the preparation of human parathyroid hormone 1-34 peptides
    Xiu, ZY
    Li, M
    Zhou, SJ
    Dou, H
    Zhou, HY
    Chen, CQ
    BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY, 2002, 36 (02) : 111 - 117
  • [34] TEH OCCURRENCE OF HYPERCALCAEMIA IN PATIENTS COMMENCING RECOMBINANT PARATHYROID HORMONE (1-34) THERAPY
    Mahon, J. H.
    McCarron, E. H.
    Robinson, V.
    Drumm, B.
    Fitzgerald, K.
    Walsh, J. B.
    Casey, M. C.
    OSTEOPOROSIS INTERNATIONAL, 2012, 23 : S344 - S344
  • [35] Teriparatide (hPTH-[1-34]) - A recombinant human parathyroid hormone fragment with anabolic actions for the treatment of osteoporosis
    Ashworth, LE
    FORMULARY, 2002, 37 (03) : 129 - +
  • [36] Effects of recombinant human parathyroid hormone (1-34) on cell proliferation, chemokine expression and the Hedgehog pathway in keratinocytes
    Bu, Xiaolin
    Bi, Xinling
    Wang, Wuqing
    Shi, Yuling
    Hou, Qiang
    Gu, Jun
    MOLECULAR MEDICINE REPORTS, 2018, 17 (04) : 5589 - 5594
  • [37] Enhancement of experimental fracture-healing by systemic administration of recombinant human parathyroid hormone (PTH 1-34)
    Alkhiary, YM
    Gerstenfeld, LC
    Krall, E
    Westmore, M
    Sato, M
    Mitlak, BH
    Einhorn, TA
    JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2005, 87A (04): : 731 - 741
  • [38] Efficacy and safety of recombinant human parathyroid hormone (1-34) are similar to those of alendronate in the treatment of postmenopausal osteoporosis
    Deng, Jing
    Feng, Zhengping
    Li, Yue
    Pan, Tingting
    Li, Qifu
    Zhao, Changhong
    MEDICINE, 2018, 97 (47)
  • [39] Preparation and characterization of a novel recombinant human parathyroid hormone (1-34) analog (Gly1-Gln26-rhPTH(1-34)) with enhanced biological activity
    Xu, Xiao-Chao
    Zhong, Shao-Dong
    Kai, Fan
    Li, Ling-Rui
    Liu, Chao
    Liu, Bo
    Bao, Jin-Ku
    PROTEIN AND PEPTIDE LETTERS, 2008, 15 (08): : 854 - 860
  • [40] Commentary on clinical safety of recombinant human parathyroid hormone 1-34 in the treatment of osteoporosis in men and postmenopausal women
    Tashjian, AH
    Chabner, BA
    JOURNAL OF BONE AND MINERAL RESEARCH, 2002, 17 (07) : 1151 - 1161
12345